FIXIN
LIVE

Serial Number

79427223

Owner

INTRAUMA S.P.A.

Attorney

William Bak

Filing Date

Mar 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

FIXIN Trademark

Serial Number: 79427223

FIXIN is a trademark filed by INTRAUMA S.P.A. on March 18, 2025. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

INTRAUMA S.P.A.

Via Antonio Meucci, 5

Entity Type: 99

Trademark Details

Filing Date

March 18, 2025

Registration Date

Not Registered

Published for Opposition

May 12, 2026

Goods & Services

Plates, braces, screws, nails and related instruments in the nature of orthopedic implants for veterinary traumatology and orthopaedics, namely, implants for the treatment of bone fractures and degenerative bone diseases and joint diseases in animals.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2026 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 20, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2026 COAR
REFUSAL PROCESSED BY IB
Oct 24, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 9, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 9, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 26, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 25, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 18, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 3, 2025 REPR